256 related articles for article (PubMed ID: 9210625)
21. Effect of pentoxifylline in rat and swine models of hepatic fibrosis: role of fibroproliferation in its mechanism.
Peterson TC; Neumeister M
Immunopharmacology; 1996 Mar; 31(2-3):183-93. PubMed ID: 8861744
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms of a clonidine-induced decrease in portal pressure in normal and cirrhotic conscious rats.
Roulot D; Braillon A; Gaudin C; Ozier Y; Girod C; Lebrec D
Hepatology; 1989 Oct; 10(4):477-81. PubMed ID: 2777209
[TBL] [Abstract][Full Text] [Related]
23. Renal vasoactive mediator generation in portal hypertensive and bile duct ligated rats.
Ackerman Z; Karmeli F; Amir G; Rachmilewitz D
J Hepatol; 1996 Apr; 24(4):478-86. PubMed ID: 8738735
[TBL] [Abstract][Full Text] [Related]
24. Hemodynamic features of advanced cirrhosis due to chronic bile duct ligation.
Katsuta Y; Zhang XJ; Ohsuga M; Akimoto T; Komeichi H; Shimizu S; Inami T; Miyamoto A; Satomura K; Takano T
J Nippon Med Sch; 2005 Aug; 72(4):217-25. PubMed ID: 16113492
[TBL] [Abstract][Full Text] [Related]
25. Microbiota transplants from feces or gut content attenuated portal hypertension and portosystemic collaterals in cirrhotic rats.
Huang HC; Tsai MH; Chang CC; Pun CK; Huang YH; Hou MC; Lee FY; Hsu SJ
Clin Sci (Lond); 2021 Dec; 135(24):2709-2728. PubMed ID: 34870313
[TBL] [Abstract][Full Text] [Related]
26. Hemodynamic characterization of chronic bile duct-ligated rats: effect of pentobarbital sodium.
Lee SS; Girod C; Braillon A; Hadengue A; Lebrec D
Am J Physiol; 1986 Aug; 251(2 Pt 1):G176-80. PubMed ID: 3740260
[TBL] [Abstract][Full Text] [Related]
27. Nebivolol treatment increases splanchnic blood flow and portal pressure in cirrhotic rats via modulation of nitric oxide signalling.
Reiberger T; Payer BA; Schwabl P; Hayden H; Horvatits T; Jäger B; Hummel T; Mitterhauser M; Trauner M; Fuhrmann V; Angermayr B; Peck-Radosavljevic M;
Liver Int; 2013 Apr; 33(4):561-8. PubMed ID: 23331709
[TBL] [Abstract][Full Text] [Related]
28. Antagonism of sphingosine 1-phosphate receptor 2 causes a selective reduction of portal vein pressure in bile duct-ligated rodents.
Kageyama Y; Ikeda H; Watanabe N; Nagamine M; Kusumoto Y; Yashiro M; Satoh Y; Shimosawa T; Shinozaki K; Tomiya T; Inoue Y; Nishikawa T; Ohtomo N; Tanoue Y; Yokota H; Koyama T; Ishimaru K; Okamoto Y; Takuwa Y; Koike K; Yatomi Y
Hepatology; 2012 Oct; 56(4):1427-38. PubMed ID: 22505286
[TBL] [Abstract][Full Text] [Related]
29. Droxidopa, an oral norepinephrine precursor, improves hemodynamic and renal alterations of portal hypertensive rats.
Coll M; Rodriguez S; Raurell I; Ezkurdia N; Brull A; Augustin S; Guardia J; Esteban R; Martell M; Genescà J
Hepatology; 2012 Nov; 56(5):1849-60. PubMed ID: 22610782
[TBL] [Abstract][Full Text] [Related]
30. Mixed endothelin receptor antagonist, SB209670, decreases portal pressure in biliary cirrhotic rats in vivo by reducing portal venous system resistance.
Kojima H; Yamao J; Tsujimoto T; Uemura M; Takaya A; Fukui H
J Hepatol; 2000 Jan; 32(1):43-50. PubMed ID: 10673066
[TBL] [Abstract][Full Text] [Related]
31. Acute haemodynamic effects of losartan in anaesthetized cirrhotic rats.
Heller J; Shiozawa T; Trebicka J; Hennenberg M; Schepke M; Neef M; Sauerbruch T
Eur J Clin Invest; 2003 Nov; 33(11):1006-12. PubMed ID: 14636305
[TBL] [Abstract][Full Text] [Related]
32. Hemodynamic changes after ligation of a major branch of the portal vein in rats: comparison with rats with portal vein constriction.
Um SH; Nishida O; Tokubayashi M; Kimura F; Takimoto Y; Yoshioka H; Inque R; Kita T
Hepatology; 1994 Jan; 19(1):202-9. PubMed ID: 8276356
[TBL] [Abstract][Full Text] [Related]
33. Pioglitazone decreases portosystemic shunting by modulating inflammation and angiogenesis in cirrhotic and non-cirrhotic portal hypertensive rats.
Schwabl P; Payer BA; Grahovac J; Klein S; Horvatits T; Mitterhauser M; Stift J; Boucher Y; Trebicka J; Trauner M; Angermayr B; Fuhrmann V; Reiberger T; Peck-Radosavljevic M
J Hepatol; 2014 Jun; 60(6):1135-42. PubMed ID: 24530596
[TBL] [Abstract][Full Text] [Related]
34. Hepatic stellate cells (Ito cells) but not collagen IV may partly be responsible for lower portal pressure after reversing secondary biliary cirrhosis in the rat.
Zimmermann H; Fellay M; Zimmermann A
J Hepatol; 1997 Jan; 26(1):158-66. PubMed ID: 9148007
[TBL] [Abstract][Full Text] [Related]
35. Chronic bile duct ligation in the dog: hemodynamic characterization of a portal hypertensive model.
Bosch J; Enriquez R; Groszmann RJ; Storer EH
Hepatology; 1983; 3(6):1002-7. PubMed ID: 6629314
[TBL] [Abstract][Full Text] [Related]
36. The relation of periportal fibrosis to portal hypertension.
Shibayama Y; Nakata K
J Hepatol; 1990 Nov; 11(3):313-7. PubMed ID: 2290021
[TBL] [Abstract][Full Text] [Related]
37. Portosystemic collaterals are not prerequisites for the development of hepatic encephalopathy in cirrhotic rats.
Hsin IF; Wang SS; Huang HC; Lee FY; Chan CY; Chang CC; Hsu CY; Lin HC; Lee SD
J Chin Med Assoc; 2012 Jan; 75(1):3-9. PubMed ID: 22240529
[TBL] [Abstract][Full Text] [Related]
38. Haemodynamic and renal evolution of the bile duct-ligated rat.
Martínez-Prieto C; Ortíz MC; Fortepiani LA; Ruiz-Maciá J; Atucha NM; García-Estañ J
Clin Sci (Lond); 2000 May; 98(5):611-7. PubMed ID: 10781394
[TBL] [Abstract][Full Text] [Related]
39. Effects of terlipressin on hemodynamics and oxygen content in conscious portal vein stenosed and cirrhotic rats receiving propranolol.
Lebrec D; Moreau R; Cailmail S; Sogni P; Oberti F; Hadengue A
J Hepatol; 1993 Jan; 17(1):102-7. PubMed ID: 8445208
[TBL] [Abstract][Full Text] [Related]
40. Effects of the administration of pentoxifylline and prednisolone on the evolution of portal fibrogenesis secondary to biliary obstruction in growing animals: immunohistochemical analysis of the expression of TGF-β and VEGF.
Andrade Wde C; Silva LF; Coelho MC; Tannuri AC; Alves VA; Tannuri U
Clinics (Sao Paulo); 2012 Dec; 67(12):1455-61. PubMed ID: 23295601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
